BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18307875)

  • 1. [Mantle cell lymphoma: clinicopathologic features and prognostic factors of 102 cases occurring in Chinese patients].
    Ji H; Li GD; Li FY; Bai YQ; Chen Y; Yang MZ; Wang LJ; Tang Y; Zhang P; Xia T; Li C; Feng J; Zou ZK; Yixi JC
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):730-5. PubMed ID: 18307875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases].
    Yang H; Lang RG; Liu FF; Wang XF; Jin ZJ; Lü AJ; Wang Y; Fu XL; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):79-84. PubMed ID: 21426801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic features of mantle cell lymphoma and the significance of cyclin D1 in diagnosis].
    He X; Li G; Liu W; Lin Y; Li F; Liao D
    Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):300-4. PubMed ID: 12417084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary lymphoma of breast: a clinicopathologic, immunophenotypic and prognostic study of 21 cases].
    Wang XQ; Zhang LX; Bi CF; Luo TY; Lin L; Min M; Zhao Y; He GX; Feng J; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):302-7. PubMed ID: 20654152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma.
    Ying ZT; Zheng W; Wang XP; Xie Y; Tu MF; Lin NJ; Ping LY; Liu WP; Deng LJ; Zhang C; Zhu J; Song YQ
    Chin J Cancer; 2012 Jul; 31(7):348-53. PubMed ID: 22704490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic features of lymphoplasmacytic lymphoma].
    Liu EB; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):308-12. PubMed ID: 20654153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
    [No Abstract]   [Full Text] [Related]  

  • 10. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
    Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic features and prognosis of gastrointestinal mantle cell lymphoma].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):763-768. PubMed ID: 30317731
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
    Wang C; Li W; Liu C; He H; Bai O
    Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic characteristics and prognositic indicators of tonsillar mantle cell lymphoma].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):158-162. PubMed ID: 29534352
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicopathologic analysis of intestinal follicular lymphoma first presenting with gastrointestinal symptoms].
    Xie JL; Jin Y; Zheng XD; Wei XJ; Zhu H; Zheng YY; Zhang SH; Zhang YN; Chen GY; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):320-5. PubMed ID: 22883671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma with skin invasion characterized by the common variant in the subcutis and blastoid transformation in the overlying dermis.
    Ishibashi M; Yamamoto K; Kudo S; Chen KR
    Am J Dermatopathol; 2010 Apr; 32(2):180-2. PubMed ID: 20010283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoplasmacytic lymphoma with Waldenström's macroglobulinemia: a clinicopathological and immunophenotypic study of 40 Chinese patients].
    Liang DN; Li GD; Dai L; Huang J; Wang WY; Feng WH; Li FY; Liao DY
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):728-32. PubMed ID: 20079010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
    Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.